Stock Analiz

QT Imaging Holdings, Inc. QTI

Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026

$1.88Market cap $28M
Open the interactive analysis →

QT Imaging Holdings, Inc. (QTI) is a healthcare company listed in the US with a market value of about $28M. In the twelve months to September 30, 2026 it had revenue of $30M and net income of -$16M, a net margin of -54.6%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).

Key numbers: a 5-year average ROIC of -430%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 7% above the current price.

About QT Imaging

QT Imaging is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus. It was profitable in 0 of the last 5 years in our data. Its share count rose by 381% over three years (dilution for shareholders). It spends 21% of revenue on research and development.

Score: 1.0 / 5

Value1/5
Future growth3/5
Track record0/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.9
P/B10.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-51.1%
Shareholder yield0.0%
Intrinsic value vs. price+7%

Growth and quality

Revenue growth (1 yr)287.9%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-5136.3%
ROIC (5-yr avg.)-429.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$30M$19M$5M$40355$0—
Net income-$16M-$21M-$9M-$6M-$3M-$1M
Free cash flow-$14M-$9M-$10M-$3M——
EPS (diluted)$-0.91$-2.01$-2.13$-1.92$-1.80$-0.42
Net margin-54.6%-111.4%-184.2%-15113.2%——
ROIC—-25.8%-833.5%———

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 4 analysts is $8.75, 365% above the current price; targets range from $6.00 to $12.00; the consensus rating is “Strong buy”; expected EPS is $-1.01 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is QT Imaging stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 7% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does QT Imaging pay a dividend?

Not currently.

Is QT Imaging a good stock to buy?

We do not give buy or sell advice. QT Imaging scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.